Typicality: | 0.422 |
Saliency: | 0.176 |
in the u.s. | 4 | location |
like phase | 2 | temporal |
trial → be conducted at → two prestigious cancer centers | 6 |
trial → be conducted at → cancer centers | 3 |
negative | neutral | positive |
0.020 | 0.770 | 0.211 |
Raw frequency | 9 |
Normalized frequency | 0.176 |
Modifier score | 0.800 |
Perplexity | 100.266 |